Vertex Pharmaceuticals ( VRTX 2.72%) had a fine Tuesday on the stock exchange. The biotech 's shares closed the day nearly 3% ...

Vertex Pharmaceuticals made headlines with a 14% share price jump, despite an overall market dip, thanks to clinical wins and ...

Elastic (NYSE: ESTC), the Search AI Company, announced that the Elasticsearch vector database is now a natively supported information retrieval engine for Google Cloud's Vertex AI platform.

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing.

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

At the 2025 Napa Valley Biotech Forum, JPMorgan analyst Jessica Fye walked away with a bullish tone after conversations with Vertex CEO Reshma Kewalramani and Senior Vice President of Investor ...

Vertex Pharmaceuticals' approved therapies and pipeline make it especially tariff-resistant. Stocks are sinking the most since the COVID-19-fueled sell-off in 2020. A global trade war seems imminent.

Vertex Securities Ltd share price was up by 0.44% from the previous closing price of ₹4.57. Who are peers of Vertex Securities Ltd? The peers of Vertex Securities Ltd are Motilal Oswal Financial ...